ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 335753 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 335753; 2) Community: the network communities that were significantly associated with the response to NSC 335753; 3) Molecule: the relationships between components within communities and NSC 335753; 4) MDR: the compounds that were significantly associated with the NSC 335753.

NSC Compound Enrichment Correlation
NSC 708559 Benzeneacetamide, 3,4-dichloro-N-methyl-N-[3- [(methyl)[3-(1-pyrrolidinyl)propyl]amino]propyl]-, diethanedioate (dioxalate) 0.0430505868034761 0.2006222
NSC 719715 Null 0.0430505868034761 0.41463192
NSC 722867 Null 0.0430505868034761 0.29291938
NSC 723548 Null 0.0430505868034761 0.49717152
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0430505868034761 0.42490673
NSC 726267 Null 0.0430505868034761 -0.12385462
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0430505868034761 0.43987555
NSC 735030 Null 0.0430505868034761 0.39274682
NSC 736811 Null 0.0430505868034761 0.29136347
NSC 740 Methotrexate 0.0430505868034761 0.35565209
Total:148  Current:132    [First] [Prev] [Next] [Last]